OTCMKTS:RCDTF - Recordati Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $37.37 0.00 (0.00 %) (As of 09/21/2018 04:00 PM ET)Previous Close$37.37Today's Range$37.37 - $37.3752-Week Range$42.00 - $42.00VolumeN/AAverage VolumeN/AMarket Capitalization$7.82 billionP/E Ratio23.65Dividend YieldN/ABeta0.65 Company ProfileDiscussionChartEarnings HistoryHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Recordati Industria Chimica e Farmaceutica S.p.A. engages in the research, development, manufacture, marketing, and sale of pharmaceuticals. The company offers pharmaceuticals in various therapeutic areas, including cosmetics, dermatology, dietary supplements, gynecology and obstetrics, musculo-skeletal disorders and analgesia, over the counter/non-prescription pharmaceuticals, urology, allergy, anti-infective, cardiovascular, central nervous system, endocrinology, gastrointestinal, nutrition and related areas, immunosuppressants, pain management/inflammation, generics, pneumology, antipyretics and cold preparations, endocrinology, oncology, respiratory, medical devices, and radio contrast agent, as well as ear, nose, and throat. It also provides pharmaceutical chemicals, such as active pharmaceutical ingredients and intermediates. The company operates in Europe, the Americas, Australasia, and Africa. The company was founded in 1926 and is headquartered in Milan, Italy. Recordati Industria Chimica e Farmaceutica S.p.A. is a subsidiary of Fimei S.p.A. Receive RCDTF News and Ratings via Email Sign-up to receive the latest news and ratings for RCDTF and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Private households Sub-IndustryN/A SectorMedical SymbolOTCMKTS:RCDTF CUSIPN/A Webwww.recordati.com Phone390-248-7871 Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Price-To-Earnings Trailing P/E Ratio23.65 Forward P/E RatioN/A P/E Growth2.51 Sales & Book Value Annual Sales$1.46 billion Price / Sales5.37 Cash FlowN/A Price / CashN/A Book ValueN/A Price / BookN/A Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/A Miscellaneous EmployeesN/A Outstanding Shares209,130,000Market Cap$7.82 billion Recordati (OTCMKTS:RCDTF) Frequently Asked Questions What is Recordati's stock symbol? Recordati trades on the OTCMKTS under the ticker symbol "RCDTF." When is Recordati's next earnings date? Recordati is scheduled to release their next quarterly earnings announcement on Thursday, October, 25th 2018. View Earnings Estimates for Recordati. Who are some of Recordati's key competitors? Some companies that are related to Recordati include ESSILOR Intl S/S (ESLOY), HENKEL AG & Co/S (HENKY), SUZUKI MTR CORP/ADR (SZKMY), Lafargeholcim (HCMLY), Eisai (ESALY), BAE SYS PLC/S (BAESY), PEUGEOT SA/ADR (PUGOY), RENAULT S A/ADR (RNLSY), Tesco (TSCDY), Bk COMMUNICATIO/ADR (BCMXY), ATLAS COPCO AB/S (ATLKY), Assd Brit FOODS/ADR (ASBFY), EXPERIAN PLC/ADR (EXPGY), HENNES & MAURIT/ADR (HNNMY) and Anglo American (NGLOY). Who are Recordati's key executives? Recordati's management team includes the folowing people: Mr. Alberto Recordati, Chairman (Age 65)Mr. Andrea Recordati, Vice Chairman & CEO (Age 47)Mr. Fritz Squindo, CFO, MD & Exec. Director (Age 62)Ms. Marianne Tatschke, Director of Investor Relations & Corp. CommunicationsMs. Daria Ghidoni, Director of Legal Affairs & Group Companies Has Recordati been receiving favorable news coverage? Press coverage about RCDTF stock has been trending somewhat positive on Friday, according to Accern. The research group identifies positive and negative news coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Recordati earned a media and rumor sentiment score of 0.18 on Accern's scale. They also gave headlines about the company an impact score of 46.57 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the immediate future. View Recent Headlines for Recordati. How do I buy shares of Recordati? Shares of RCDTF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Recordati's stock price today? One share of RCDTF stock can currently be purchased for approximately $37.37. How big of a company is Recordati? Recordati has a market capitalization of $7.82 billion and generates $1.46 billion in revenue each year. How can I contact Recordati? Recordati's mailing address is Via Matteo Civitali 1, Milano L6, 20148. The company can be reached via phone at 390-248-7871 or via email at [email protected] MarketBeat Community Rating for Recordati (OTCMKTS RCDTF)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 53 (Vote Outperform)Underperform Votes: 54 (Vote Underperform)Total Votes: 107MarketBeat's community ratings are surveys of what our community members think about Recordati and other stocks. Vote "Outperform" if you believe RCDTF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RCDTF will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 9/21/2018 by MarketBeat.com StaffFeatured Article: What is the Dividend Aristocrat Index?